Dysbiosis
94
18
31
37
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.2%
3 terminated out of 94 trials
92.5%
+5.9% vs benchmark
9%
8 trials in Phase 3/4
16%
6 of 37 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 37 completed trials
Clinical Trials (94)
Assessment of the Impact of Type of Probiotic, Delivery Type and Feeding Type on Baby's Microbiota After Dysbiotic Delivery
Dietary Pattern Intervention for Neurodevelopment in Preterm Infants
Metabolic and Functional Study of γδ T Cells in Critically Ill Patients
FMT for 90-Day Outcome of Clinical Use in ICU Sepsis
Pulse Education and Children
Almonds, Gut Microbiome and Kids
REMBRANDT: REcovery of the MicroBiome fRom Antibiotics for Dental implanTs
A Study of Healthy Microbiome, Healthy Mind
Probiotics Supplementation for Neurodevelopment in Preterm Infants
Association Between Fecal Microbiota Composition, Metabolite Concentrations, and Indoxyl Sulfate Levels
Impact of TAVI on the Gut Microbiota and Its Metabolites
Almonds to Improve Gut Health and Decrease Inflammation
Effect of Lentils and Chickpeas on Gut Microbiome and Metabolic Health
Prebiotic Effects of California Grapes on Gut Health and Cardiometabolic Health in Overweight Men and Women
Impact of Internal Menstrual Protections on Immunity and Vaginal Microbiota
Effect of Peanut Butter on Gut and Metabolic Health
Effect of Watermelon on Gut and Cardiometabolic Health
Microbiome Alterations With Xylitol (MAX) in Pregnancy
BioAmicus Complete for Functional Gastrointestinal Symptoms in Infants Aged 0 to 24 Months
Influences of High-fiber, Organic Whole-food Formula on the Gut Microbiome in Critically Ill Children